… (HCQ), and, very recently, ivermectin. We hypothesize that HCQ and ivermectin may show
a … both for chemoprophylaxis and treatment of COVID-19. HCQ is an antimalarial drug, an …

… safety of hydroxychloroquine and ivermectin in hospitalized patients with moderate pneumonia
secondary to COVID-19. … to COVID-19 and fulfilling hospitalization criteria, treatment with …

… of COVID-19. Towards that initiative, potential drugs like hydroxychloroquine, ivermectin …
worldwide for their potential against novel coronavirus. The present report presents together the …

… known dosing regimens of Ivermectin therapy in patients with COVID-19. [24, 25] Thus, it is
vital to investigate the dose regimens of Ivermectin for COVID-19 treatment or to determine if …

… In Brazil, unproven drugs against COVID-19, such as hydroxychloroquine and ivermectin, …
has several similarities to the use of hydroxychloroquine during COVID-19. After initial …

… are advocated as potential treatments for coronavirus disease 2019 (COVID-19) …
Hydroxychloroquine and/or Ivermectin were determined in a series of patients with confirmed …

… and continued treatment of COVID 19 with a variety of … effects of ivermectin in mild to
moderate COVID-19 patients … of an additive combination of ivermectin with a novel antiviral …

… work, such as hydroxychloroquine, or that are … ivermectin to prevent or treat COVID‐19 in
humans. People being treated with ivermectin had to have laboratory‐test confirmed COVID‐19 …

… Participants were asked if they had taken hydroxychloroquine, ivermectin, or one of the …
use in COVID-19. The primary outcome measure was use of hydroxychloroquine or ivermectin; …

… Guideline on clinical management of coronavirus disease 2019 (COVID-19) version 7.0«
were … In this study only mild to moderate COVID19 cases were included. ivermectin and …